In a study of esophageal squamous cell carcinoma, treatment with 5-ALA led to the inhibition of glutathione peroxidase 4 (GPX4), a crucial antioxidant enzyme, and upregulation of HO-1 expression in the cells [93]. The gene discussed is GPX4; the disease is esophageal squamous cell carcinoma.